Teamshares Inc. (TMS)
Live price chart, market sentiment, and community perspectives for Teamshares Inc. (NASDAQ: TMS).
Live price chart, market sentiment, and community perspectives for Teamshares Inc. (NASDAQ: TMS).
On our desk, we are seeing classic de-SPAC dilution patterns with TMS. While the Q2 2026 revenue growth of 20% to $148.7 million and a shift to positive net income of $9.5 million look attractive on paper, the market clearly lacks patience given the lingering going concern risk flagged in the 10-Q. Until debt maturities are definitively resolved, buying the dip feels like catching a falling knife.
From our quantitative lab, the six-month metrics tell a more sobering story than the headline Q2 profit. Teamshares still recorded a net loss of $13.3 million and negative free cash flow of $8.7 million for the first half of 2026. Even though cash and cash equivalents improved to $113.4 million following the June business combination, the burn rate requires careful monitoring.
As a risk manager reviewing the S-1 filing, the registration of nearly 16 million shares for warrant exercises and over 19 million shares for resale creates a massive potential stock overhang. Representing roughly 26.7% of common stock outstanding, this supply dynamic explains why the stock tumbled 13% despite a top-line beat. Full cash exercise could raise $184 million, but dilution remains a heavy near-term anchor.
Watching the 50-day MA and technical charts, TMS has suffered from broad capital outflows and weak factor scores, ranking in the weakest quartile on Ticker Nerd's systematic model. However, with a median analyst target at $14 offering massive upside from the $7.42 close, there is a stark disconnect between fundamental sell-side enthusiasm and the algorithmic caution.
On our options desk, we are tracking high implied volatility following the post-SPAC sell-off. With the company reaffirming its $60 million EBITDA outlook and delivering an LTM Pro Forma Adjusted EBITDA of $21.2 million, asymmetric opportunities might emerge if the stock stabilizes above its recent lows and confirms a bullish candlestick reversal pattern.
Explore plasma cleansing, somatic organ swaps, and BCI.